Shopping Cart
- Remove All
- Your shopping cart is currently empty
EU-103 is a humanized monoclonal antibody that targets V-Set And Immunoglobulin Domain Containing 4 (VSIG4), with a KD value range between 10^-7 and 10^-9. It disrupts the interaction between VSIG4 and CD8+ T cells, facilitating the transformation of M2 macrophages to M1 macrophages, inducing proliferation of CD8+ T cells, and promoting the secretion of pro-inflammatory cytokines, thereby inhibiting tumor growth. EU-103 shows potential for research in cancer treatment, including bladder cancer, breast cancer, and colon cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | EU-103 is a humanized monoclonal antibody that targets V-Set And Immunoglobulin Domain Containing 4 (VSIG4), with a KD value range between 10^-7 and 10^-9. It disrupts the interaction between VSIG4 and CD8+ T cells, facilitating the transformation of M2 macrophages to M1 macrophages, inducing proliferation of CD8+ T cells, and promoting the secretion of pro-inflammatory cytokines, thereby inhibiting tumor growth. EU-103 shows potential for research in cancer treatment, including bladder cancer, breast cancer, and colon cancer. |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.